A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics.

Purpose: The objective of this study was to evaluate whether extended-release hydromorphone (osmotic-controlled release oral delivery system [OROS] hydromorphone) treatment provided pain relief in cancer patients whose pain was inadequately controlled by other analgesics.Methods: In this prospective...

Descripción completa

Detalles Bibliográficos

Publicado en:	Supportive Care in Cancer Vol. 22; no. 3; pp. 741 - 751
Autores principales:	Han, Hye-Suk, Lee, Ki Hyeong, Lee, Kyung Hee, Ryu, Jeong Seon, Kim, Young Chul, Park, Seung Woo, Oh, Ho-Suk, Park, Kyung Tae, Kwon, Jung Hye, Lee, Pyung Bok, Lee, Won Sik, Kim, Yang Soo, Ahn, Joong Bae, Jeon, Seong Woo, Lee, Sung Yong, Seol, Young Mi, Kang, Jung Hun, Yuh, Young Jin, Oh, So Yeon, Kim, Suk Ran
Formato:	research Journal Article
Publicado:	Springer Nature Mar2014
Acceso en línea:	Ver este registro en EBSCOhost